Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Orange

Showing results (261-270 of 357) with videos related to

Pageof 36
Sort By:
The Journal of Allergy and Clinical Immunology|January 3, 2017
Update on the use of immunoglobulin in human disease: A review of evidenceElena E Perez, Jordan S Orange, Francisco Bonilla, et al.
The Journal of Clinical Investigation|June 5, 2002
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutationsJordan S Orange, Scott R Brodeur, Ashish Jain, et al.
The Journal of Allergy and Clinical Immunology|April 4, 2006
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJordan S Orange, Elham M Hossny, Catherine R Weiler, et al.
Scientific Reports|August 2, 2016
IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivoJoanna S Kritikou, Carin I M Dahlberg, Marisa A P Baptista, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2019
Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantationCaitlin M Burk, Kara E Coffey, Emily M Mace, et al.
The New England Journal of Medicine|November 12, 2010
Stem-cell gene therapy for the Wiskott-Aldrich syndromeKaan Boztug, Manfred Schmidt, Adrian Schwarzer, et al.
Journal of Clinical Immunology|June 7, 2018
The International Alliance of Primary Immune Deficiency SocietiesAndrew R Gennery, Roshini S Abraham, Troy R Torgerson, et al.
Blood|February 1, 2013
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subsetEmily M Mace, Amy P Hsu, Linda Monaco-Shawver, et al.
Pediatric Research|January 20, 2021
Perspectives from the Society for Pediatric Research: advice on sustaining science and mentoring during COVID-19Catherine S Forster, Suong T Nguyen, Weston T Powell, et al.
American Journal of Human Genetics|July 24, 2018
Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function AllelesZeynep Coban-Akdemir, Janson J White, Xiaofei Song, et al.
Pageof 36

Showing results (261-270 of 357) with videos related to

Sort By:
Pageof 36
The Journal of Allergy and Clinical Immunology|January 3, 2017
Update on the use of immunoglobulin in human disease: A review of evidenceElena E Perez, Jordan S Orange, Francisco Bonilla, et al.
The Journal of Clinical Investigation|June 5, 2002
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutationsJordan S Orange, Scott R Brodeur, Ashish Jain, et al.
The Journal of Allergy and Clinical Immunology|April 4, 2006
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJordan S Orange, Elham M Hossny, Catherine R Weiler, et al.
Scientific Reports|August 2, 2016
IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivoJoanna S Kritikou, Carin I M Dahlberg, Marisa A P Baptista, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2019
Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantationCaitlin M Burk, Kara E Coffey, Emily M Mace, et al.
The New England Journal of Medicine|November 12, 2010
Stem-cell gene therapy for the Wiskott-Aldrich syndromeKaan Boztug, Manfred Schmidt, Adrian Schwarzer, et al.
Journal of Clinical Immunology|June 7, 2018
The International Alliance of Primary Immune Deficiency SocietiesAndrew R Gennery, Roshini S Abraham, Troy R Torgerson, et al.
Blood|February 1, 2013
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subsetEmily M Mace, Amy P Hsu, Linda Monaco-Shawver, et al.
Pediatric Research|January 20, 2021
Perspectives from the Society for Pediatric Research: advice on sustaining science and mentoring during COVID-19Catherine S Forster, Suong T Nguyen, Weston T Powell, et al.
American Journal of Human Genetics|July 24, 2018
Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function AllelesZeynep Coban-Akdemir, Janson J White, Xiaofei Song, et al.
Pageof 36